Review of novel therapeutics in cardiac arrest (ReNTICA): systematic review protocol
- PMID: 34980619
- PMCID: PMC8724734
- DOI: 10.1136/bmjopen-2021-053304
Review of novel therapeutics in cardiac arrest (ReNTICA): systematic review protocol
Abstract
Introduction: Cardiac arrest remains a common and devastating cause of death and disability worldwide. While targeted temperature management has become standard of care to improve functional neurologic outcome, few pharmacologic interventions have shown similar promise.
Methods/analysis: This systematic review will focus on prospective human studies from 2015 to 2020 available in PubMed, Web of Science and EMBASE with a primary focus on impact on functional neurologic outcome. Prospective studies that include pharmacologic agents given during or after cardiac arrest will be included. Study selection will be in keeping with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. If sufficient data involving a given agent are available, a meta-analysis will be conducted and compared with current evidence for therapies recommended in international practice guidelines.
Ethics and dissemination: Formal ethical approval will not be required as primary data will not be collected. The results will be disseminated through peer-reviewed publication, conference presentation and lay press.
Prospero registration number: International Prospective Register for Systematic Reviews (CRD42021230216).
Keywords: accident & emergency medicine; adult cardiology; adult intensive & critical care; clinical pharmacology; neurological injury; therapeutics.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Panchal AR, Berg KM, Hirsch KG. American heart association focused update on advanced cardiovascular life support: use of advanced airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest: an update to the American heart association guidelines F. Circulation 2019;2019:E881–94. - PubMed
-
- Panchal AR, Berg KM, Kudenchuk PJ. American heart association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest: an update to the American heart association guidelines for cardiopulmonary resuscitation and em. Circulation 2018;2018:e740–9. 10.1161/CIR.0000000000000613 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical